What is Intrinsic Imaging?
Intrinsic Imaging operates at the intersection of advanced medical imaging and clinical trial management, providing essential services that enhance study timelines and improve research outcomes. As a key player in the life sciences infrastructure, the company offers comprehensive study planning, regulatory oversight, and expert trial design. Their market position is defined by a commitment to participant safety and quality compliance, leveraging robust data intelligence to support sponsors, contract research organizations, and research sites. With decades of industry experience, the firm serves as a vital partner in navigating the complexities of modern clinical development, ensuring that data integrity remains at the forefront of every study.
How much funding has Intrinsic Imaging raised?
Intrinsic Imaging has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Intrinsic Imaging
PPP
Public-Private Partnership
What's next for Intrinsic Imaging?
With the successful closure of this late-stage funding round, Intrinsic Imaging is poised to scale its technological infrastructure and broaden its service offerings. The strategic allocation of this capital will likely focus on enhancing data analytics capabilities and expanding the company's network of clinical research sites. As the demand for high-quality, compliant clinical trial data continues to rise, the firm is strategically aligned to capture further market share. Future growth initiatives will likely prioritize the integration of automated review processes and the expansion of their regulatory support services, ensuring they remain a preferred partner for global clinical research programs seeking to optimize efficiency and maintain rigorous safety standards.
See full Intrinsic Imaging company page
